Filter
3560
Filtered Results: 3560
Text search:
Center
for
Disease
Control
and
Prevention
Featured
Recommendations
316
New Publications
905
Language
Document type
No document type
2006
Studies & Reports
608
Guidelines
467
Manuals
182
Strategic & Response Plan
99
Fact sheets
76
Training Material
54
Situation Updates
39
Infographics
10
Resource Platforms
9
Online Courses
5
Brochures
3
App
1
Videos
1
Countries / Regions
India
172
Global
125
Ethiopia
105
Liberia
92
Kenya
81
Rwanda
78
Nepal
74
Latin America and the Carribbean
70
Sierra Leone
65
Africa
62
Nigeria
57
Uganda
52
Philippines
51
Western and Central Europe
51
Malawi
46
Bangladesh
43
Tanzania
40
Zambia
37
Ukraine
36
Myanmar / Burma
36
Mozambique
35
Haiti
34
Russia
33
Congo, Democratic Republic of
30
Syria
29
Cambodia
29
Brazil
29
Eastern Europe
28
Senegal
27
Guinea
26
Ghana
26
Indonesia
26
Asia
25
South Africa
23
South Sudan
20
Namibia
20
Lesotho
20
Burkina Faso
18
Zimbabwe
18
South–East Asia Region
17
Germany
16
Yemen
16
USA
15
Middle East and North Africa
15
Angola
14
West and Central Africa
14
Colombia
13
Eastern Europe and Central Asia
13
East and Southern Africa
11
Cameroon
10
Thailand
10
Argentina
9
Botswana
9
Venezuela
9
Albania
9
Guinea-Bissau
7
Pakistan
7
Afghanistan
7
Ecuador
7
Western Pacific Region
7
Georgia
7
Vietnam
7
China
6
Central African Republic
6
Eswatini/ Swaziland
6
Paraguay
6
Armenia
6
Mali
5
Jordan
5
Benin
5
Peru
5
Chile
5
Laos
5
Tajikistan
5
Moldova
5
Somalia
4
Madagascar
4
Sri Lanka
4
North America
4
Japan
4
Côte d’Ivoire / Ivory Coast
3
North Macedonia
3
Burundi
3
El Salvador
3
Bolivia
3
Mexico
3
Palestine
3
Kazakhstan
3
France
3
United Kingdom
3
Portugal
3
Spain
3
Belarus
3
Saudi Arabia
2
Iraq
2
Lebanon
2
Turkey
2
Chad
2
Malaysia
2
Honduras
2
Libya
2
Bhutan
2
Canada
2
Timor Leste/ East Timor
2
Romania
2
Gabon
2
Jamaica
2
Niger
1
Egypt
1
Papua New Guinea
1
Sudan
1
Austria
1
Switzerland
1
Hungary
1
Greece
1
Other region
1
Poland
1
Italy
1
Southern Africa
1
Qatar
1
Estonia
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Turkmenistan
1
Belgium
1
Mauritius
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1320
Clinical Guidelines
286
Public Health
205
Women & Child Health
145
Key Resources
135
Capacity Building
63
Pharmacy & Technologies
39
Toolboxes
COVID-19
375
HIV
306
Mental Health
255
TB
219
AMR
159
Ebola
137
Planetary Health
115
Rapid Response
114
NTDs
111
Caregiver
84
NCDs
77
Conflict
58
Global Health Education
58
Disability
55
Refugee
52
Pharmacy
50
Zika
49
Natural Hazards
44
Cholera
38
Health Financing Toolbox
33
Specific Hazards
23
Polio
15
Social Ethics
4
Typhoon
2
Health Financing
2
South Sudan
1
This document provides guidance on the implementation of the shielding approach in camps and camp-like settings for refugees and i...
Infectious disease outbreaks and epidemics are increasing in frequency, scale and impact. Health care facilities can amplify the transmission of em...
8 March 2022
A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neig...
The article outlines the prioritized research agenda for the prevention and control of chronic r...
https://doi.org/10.1371/journal.pntd.0002439
South Sudan has a high burden – among the highest in sub-Saharan Africa – of neglected tropical diseases (NTDs). This adversely affects the health and...
A Manual for Medical Officer
Developed under the Government of India – WHO Collaborative Programme 2008-2009
Accessed: 11.03.2019
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality ... morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IPC) is a key pillar in the outbreak response; adherence to IPC practices can prevent and control transmission of infections to health and care workers, patients and their family members.
During the 2014-2016 West African Ebola disease outbreak, there was an urgent need for rapid IPC guidance to help support ministries of health, health-care providers and non-governmental organizations (NGOs). In response, WHO produced several documents related to the outbreak based on expert opinion, including IPC-specific documents and documents on clinical management that also referenced key IPC principles and practices. Since that time, many practices in the field have become institutionalized.
Accessed: 02.05.2020
These interim IPC recommendations for health settings have been developed through the contributions of many individuals and institutions, such as the Centers ... Disease Control-Kenya; ITECH; US Agency for International Development (USAID) Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program; and WHO that are committed to ensuring that the transmission of COVID-19 to HCWs and the public within the health care setting is limited. The Ministry of Health (MOH) through the Directorate of Health Standards Quality Assurance and Regulations wishes to thank all the contributing authors led by the sub-committee on case management and IPC for the COVID-19 response for their expertise and time given to writing these guidelines.
This module covers common Non-Communicable Diseases such as Hypertension, Diabetes and three common cancers (Cervical,
Breast and Oral cancer). Th...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested.
Cancer, diabetes, heart disease and stroke, chronic respiratory disease
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-he...
The Government of the Republic of Zambia has placed priority on ensuring that Zambians are healthy and productive as a catalyst to the attainment of socioeconomic development . The Vision 2030 aims to transform Zambia into a prosperous middle-income...
This interim guidance is for LTCF managers and corresponding infection prevention and ... (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus from entering the facility and spreading within the facility, and 2) to support safe conditions for visiting through the rigorous application of IPC procedures for the residents’ well-being. WHO will update these recommendations as new information becomes available.
Availabel in English, French, Russian and Spanish
Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD ... focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discusses the implications of such a focus. It then outlines the opportunities for those in public health and environmental science to work together across three key areas to address air pollution, NCDs and climate change: (a) acknowledging the shared drivers, including corporate determinants; (b) taking a ‘co-benefits’ approach to NCD prevention; and (c) expanding prevention research and evaluation methods through investing in systems thinking and intersectoral, cross-disciplinary collaborations.
